BMY vs DOCS · P/E 17, rev $48.19B vs P/E 21, rev $570.4M
Bristol-Myers Squibb Company (BMY) versus Doximity Inc (DOCS) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Doximity Inc (DOCS) is a health information services company listed on US.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Not investment advice. Open the BMY and DOCS stock pages for the full models.
Not investment advice.